Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Maha Behairy"'
Publikováno v:
The Egyptian Heart Journal, Vol 70, Iss 1, Pp 27-33 (2018)
Background: Cardiovascular diseases (CVDs) are a major cause of morbidity and mortality in patients with end stage renal disease (ESRD). Circulating endotoxins may have toxic effect on myocardial functions and are speculated as pathogens of accelerat
Externí odkaz:
https://doaj.org/article/e66984b1f1ec4442b27c584599cd3c36
Publikováno v:
Journal of Nephropathology, Vol 5, Iss 3, Pp 105-110 (2016)
Background: Forkhead box P3 (Foxp3) functions as a master regulator in the development and function of T-regulatory (Treg) cells. Recent studies have shown that autoimmune diseases including systemic lupus erythematosus (SLE) are associated with an i
Externí odkaz:
https://doaj.org/article/d97e36e0fae5494886456f726bc4214e
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 26, Iss 1, Pp 26-33 (2015)
Left ventricular hypertrophy (LVH) and left ventricular dysfunction are highly prevalent in patients with end-stage renal disease (ESRD). Several studies suggest that left ventricular mass and function is strongly modulated by the nitric oxide (NO) s
Externí odkaz:
https://doaj.org/article/2fb3d00f758a4ae280c03ada0bd072f0
Publikováno v:
International Urology and Nephrology. 53:2593-2601
Non-alcoholic fatty liver disease (NAFLD) shares a close relationship with cardiovascular morbidity and mortality. The purpose of this study is to evaluate the frequency of NAFLD in the patients with non-diabetic chronic kidney disease (CKD). This cr
Publikováno v:
QJM: An International Journal of Medicine. 114
Background/Aim Preliminary data suggest an association between chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD). The aim of this study was evaluate the frequency of NAFLD and its associated risk factors among nondiabetic CKD
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 1, Pp e5-e5 (2022)
Background Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objectives M
Publikováno v:
Journal of Nephropharmacology, Vol 9, Iss 1, Pp e03-e03 (2020)
Introduction: Intravenous (IV) iron which is a potent pro-oxidant may decrease the phagocytic function of neutrophils and subsequently leads to repeated bacterial infections in patients on chronic regular hemodialysis (HD).Objectives: We aimed to eva
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 55, Iss 1, Pp 1-5 (2019)
Background Cerebrovascular accidents and cognitive impairment is a frequent complication of end-stage renal disease (ESRD) on regular hemodialysis (HD). Objective To evaluate cerebral circulation hemodynamics in non-diabetic prevalent hemodialysis pa
Autor:
Maha Behairy, Heba W. El Said, Hesham A Abou Elleil, Mohamed M. Mohamed, Khaled Abou Seif, Fatma Ahmed, Tamer Wahid El Said, Yasser S Ahmed
Publikováno v:
Nephrology. 23:323-330
Aim Iron overload is frequently reported in haemodialysis (HD) patients particularly those with chronic hepatitis C virus (HCV) infection. Soluble haemojuvelin (sHJV) has recently emerged as one of the significant regulators of iron homeostasis and h
Publikováno v:
Nefrología, Vol 38, Iss 1, Pp 64-72 (2018)
Nefrología (English Edition), Vol 38, Iss 1, Pp 64-72 (2018)
Nefrología (Madrid) v.38 n.1 2018
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Nefrología (English Edition), Vol 38, Iss 1, Pp 64-72 (2018)
Nefrología (Madrid) v.38 n.1 2018
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Podocalyxin is an electronegative sialoglycoprotein that prevents the podocyte foot process from collapsing. The aim of this study was to detect an association between the glomerular immunohistochemical (IHC) expression of podocalyxin and the degree